Your product is now available from Integrated DNA Technologies.
Many of the Swift products you have grown to love are now part of our new complete portfolio, xGen™ NGS. Through this new partnership we are pleased to offer you comprehensive next generation sequencing solutions.
xGen NGS—made for you.
Unsure of what products are available? Or, perhaps you’d like guidance on which products are compatible? If so, try our xGen NGS Solutions Builder Tool today.
Welcome to the IDT family!
Find Archer now at IDT!
All Archer information is now available on IDT’s website. You can view Archer assays alongside IDT’s xGen™ NGS portfolio to find the best next generation sequencing solution for your lab.
Confidently detect more with Archer NGS assay solutions for your solid tumor, blood cancer, immune profiling, and genetic disease research.
Choose your region, country/territory, and preferred language
Frequently asked questions
Our Scientific Applications Support team has assembled a list of frequently asked questions to help you find answers quickly. Filter using one or more categories to focus on specific topics, or use the search bar to perform a text search.
Search all FAQs:
How do I choose which two guide RNAs to multiplex, when using the Alt-R™ nickases?
There are multiple factors to consider when selecting the guide RNAs to multiplex with Cas9 nickase:
Each crRNA should function efficiently in individual genome editing experiments.
The two guide RNAs must target opposite strands to ensure a double-strand break is created.
Distance between cleavage sites is important for optimal performance.
Alt-R Cas9 D10A Nickase 3NLS: 40–70 bp
Alt-R Cas9 H840A Nickase 3NLS: 50–70 bp
Outward PAM site orientation (right side)
For more information about the design and use of Cas9 nickases, refer to the application note at www.idtdna.com/CRISPR-Cas9 (Support section).